Evogene Ltd. news
Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announced today its financial results for the first quarter ending March 31, 2019.
Ofer Haviv, Evogene’s President and CEO, stated: “In 2019 we have completed the transition, as planned, to our new corporate structure consisting of Evogene, the company, as a technology hub for multiple divisions and subsidiaries in differ
Evofuel Ltd., a company focused on securing the global demand for stable castor oil supply and a wholly owned subsidiary of Evogene Ltd. (NASDAQ, TASE: EVGN), announced today that its CEO, Mr. Assaf Dotan, will present at 2019 ICOA Conference to take place on the 21st-23rd of May, 2019 in Dubrovnick, Croatia.
Mr. Assaf Dotan will present the company’s new vision and branding. The company’s new corporate presentation is available on E
Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announced today that it will release its financial results for the first quarter of 2019 on Tuesday, May 28, 2019. Dr. Arnon Heyman, CEO of Evogene’s cannabis subsidiary, Canonic, will join the conference call to discuss the company’s activity with highlights from Canonic’s